• KOL
    • Bipolar Disorder
    • Faith B Dickerson
    • Faith B Dickerson: Influence Statistics

      Faith B Dickerson

      Faith B Dickerson

      Sheppard Pratt, Baltimore, MD | Sheppard Pratt, Baltimore, MD, USA | College of Medicine, University of Arizona, Tucson, AZ, USA | Sheppard Pratt, Baltimore, MD 21204, USA;, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Faith B Dickerson:Expert Impact

      Concepts for whichFaith B Dickersonhas direct influence:Bipolar disorder,Mental illness,Cognitive functioning,Onset psychosis,Herpes simplex virus,Acute mania,Individuals schizophrenia,Simplex virus.

      Faith B Dickerson:KOL impact

      Concepts related to the work of other authors for whichfor which Faith B Dickerson has influence:Bipolar disorder,Mental illness,Patients schizophrenia,Gut microbiota,Physical activity,Negative symptoms,Cognitive impairment.

      KOL Resume for Faith B Dickerson

      Year
      2022

      Sheppard Pratt, Baltimore, MD

      College of Medicine, University of Arizona, Tucson, AZ, USA

      2021

      Stanley Research Program, Sheppard Pratt, Baltimore, MD, USA.

      Sheppard Pratt (Dickerson, Katsafanas, Newman, Origoni, Rowe, Squire, Ziemann, Khushalani) and Johns Hopkins University School of Medicine (Yolken), Baltimore.

      2020

      Sheppard Pratt Health System, Towson, MD, United States

      Stanley Division of Developmental Neurovirology, USA

      2019

      Stanley Research Program, Sheppard Pratt Health System, Baltimore, MD 21204, United States

      Sheppard Pratt Health System, Baltimore, MD, USA.

      2018

      Department of Psychology and.

      Stanley Research Program, Sheppard Pratt Health System, Baltimore, MD 21204, USA

      2017

      Sheppard Pratt Hospital

      2016

      e Department of Pediatrics , Johns Hopkins School of Medicine , Baltimore , MD , USA.

      2015

      Stanley Research Program, Sheppard Pratt, Baltimore, MD, USA

      Sheppard Pratt Health System, Baltimore, MD, United States of America

      2014

      Stanley Research Program at Sheppard Pratt, Sheppard Pratt Health System (Drs Dickerson, Goga, and Khushalani and Mss Stallings, Origoni, Katsafanas, Savage, and Schweinfurth); and Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine (Dr Yolken), Baltimore, Maryland.

      Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA

      Sheppard Pratt Health System, Baltimore, MD

      2013

      Sheppard and Enoch Pratt Hospital, Baltimore, Maryland, USA

      Dr. Schroeder is with Schroeder Statistical Consulting LLC, Ellicott City, Maryland.

      2012

      The Stanley Research Program at Sheppard Pratt

      Department of Pediatrics, Stanley Division, 600 N. Wolfe Street, Blalock 1105, Johns Hopkins University, Baltimore, MD 21287, USA

      2011

      *Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD; †VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center, Baltimore, MD; ‡Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD; and §Sheppard Pratt Health System, Baltimore, MD.

      Sheppard Pratt, 6501 North Charles St., Baltimore, MD 21204, United States

      2010

      Stanley Research Program, Sheppard and Enoch Pratt Hospital, Baltimore, Maryland, United States

      Sheppard Pratt, Baltimore, MD 21204, USA

      2009

      *Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD; †Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; ‡Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD; §Stanley Research Center, Sheppard Pratt Health System, Baltimore, MD; and ¶Department of Family and Community Health, University of Maryland School of Nursing, Baltimore, MD.

      Sheppard Pratt Health System, 6501 North Charles St., Baltimore, MD, 21204 USA

      Sample of concepts for which Faith B Dickerson is among the top experts in the world.
      Concept World rank
      social learning 1950s #1
      variables employment status #1
      expanded version anchors #1
      raters total #1
      residential independence #1
      tailored exercise sessions #1
      anchors mcas #1
      questionnaires 87–99 #1
      sfs mcas #1
      schizophrenia older women #1
      mental illness review #1
      socialization wechsler scales #1
      strategies empowerment #1
      qoli sfs #1
      cesq #1
      mild moderate maladjustment #1
      predictors residential independence #1
      cbt interventions patient #1
      peer providers services #1
      residual symptoms addition #1
      ratings caregivers #1
      outcome rehabilitation interventions #1
      quantity cigarettes #1
      nonsmokers gender #1
      fulltime competitive employment #1
      peer providers tobacco #1
      shared variance sfs #1
      economy schizophrenia #1
      delusions relative efficacy #1
      total allopurinol #1
      barriers persons #1
      techniques cognitive deficits #1
      overweight obesity issues #1
      implementation strategies literature #1
      measured repeatable #1
      bipolar disorder n26 #1
      pervasive disruptive effects #1
      20 achieve participants #1
      life variance baltimore #1
      behaviors highest concordance #1
      symptom levels severity #1
      persons potential danger #1
      adjunctive valacyclovir #1
      defining characteristic schizophrenia #1
      n51 completers #1
      anchors interview probes #1
      interview probes #1
      interview probes assessment #1
      instruments common content #1
      treatment refractory symptoms #1

      Prominent publications by Faith B Dickerson

      KOL-Index: 15818

      OBJECTIVES: We investigated the effect of elevated levels of C-reactive protein (CRP) and exposure to Herpes simplex virus type 1 (HSV-1) on the severity of cognitive impairment in individuals with schizophrenia.

      METHODS: We measured the levels of CRP and of antibodies to HSV-1 in serum samples from 588 individuals with schizophrenia by enzyme immunoassay tests. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and ...

      Known for Cognitive Impairment | Herpes Simplex | Individuals Schizophrenia | Elevated Levels | Reactive Protein
      KOL-Index: 14180

      BACKGROUND: In a previous investigation, we found an association between reduced cognitive functioning and the prevalence of antibodies to herpes simplex virus type 1 in individuals with schizophrenia. The current study was undertaken to determine if this association also occurs in individuals with bipolar disorder.

      METHODS: Cognitive functioning and serologic evidence of infection with potentially neurotropic herpesviruses were measured in 117 individuals with bipolar disorder and in ...

      Known for Bipolar Disorder | Simplex Virus Type | Cognitive Functioning | Infection Herpes | Serologic Evidence
      KOL-Index: 14013

      OBJECTIVES: Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), which may lead to inappropriate treatment and poor outcomes. This study aimed to compare demographic and clinical features between patients with MDD and those with BD, but being misdiagnosed as MDD, in China.

      METHODS: A total of 1487 patients diagnosed with MDD were consecutively evaluated in 13 psychiatric hospitals or psychiatric units of general hospitals nationwide in China. The patients' ...

      Known for Bipolar Disorder | Major Depressive | Patients Mdd | Psychotic Symptoms | Onset 95
      KOL-Index: 13227

      OBJECTIVE: This study examined the prevalence of cigarette smoking and the quantity of cigarettes consumed by individuals with schizophrenia or bipolar disorder and by those with no psychiatric disorder in the period 1999-2011.

      METHODS: A total of 991 individuals with schizophrenia, bipolar disorder, or no psychiatric illness provided information about their cigarette smoking at recruitment into a research study for which they were selected without regard to their smoking status. ...

      Known for Cigarette Smoking | Bipolar Disorder | Individuals Schizophrenia | Psychiatric Illness | Study Prevalence
      KOL-Index: 12713

      BACKGROUND: Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness.

      METHODS: We recruited overweight or obese ...

      Known for Mental Illness | Loss Intervention | Behavioral Weight | 18 Months | Control Participants
      KOL-Index: 12248

      BACKGROUND: Prior reports of decreased levels of essential fatty acids among schizophrenic patients have generated several hypotheses proposing inherent abnormalities in phospholipid and fatty acid metabolism and have provided the basis for treatment trials; however, these essential fatty acid aberrations may be attributable to uncontrolled factors, such as smoking, rather than abnormalities inherent to schizophrenia.

      METHODS: Erythrocyte fatty acid compositions were quantified in 72 ...

      Known for Fatty Acid | Schizophrenic Patients | Schizoaffective Disorder | Dietary Intake | Factors Smoking
      KOL-Index: 11859

      The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) and Treatment Units for Research on Neurocognition and Schizophrenia projects were designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia. The MATRICS project identified three drug mechanisms of particular interest: dopaminergic, cholinergic, and glutamatergic. As a group, while people with schizophrenia have moderate cognitive ...

      Known for Galantamine Memantine | Cognition Schizophrenia | Cognitive Impairment | Approved Medications | Drug Mechanisms
      KOL-Index: 11729

      Cognitive impairment is a core feature of schizophrenia. Previous studies have indicated that exposure to neurotropic infectious agents such as Herpes Simplex Virus type 1 may contribute to cognitive deficits and neuroanatomical abnormalities in individuals with schizophrenia. We examined the association between exposure to neurotropic infectious agents and cognitive function in 1308 participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial. This ...

      Known for Herpes Simplex Virus | Cognitive Deficits | Type 1 | Individuals Schizophrenia | Serological Evidence
      KOL-Index: 11643

      The Schizophrenia Patient Outcomes Research Team (PORT) psychosocial treatment recommendations provide a comprehensive summary of current evidence-based psychosocial treatment interventions for persons with schizophrenia. There have been 2 previous sets of psychosocial treatment recommendations (Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24:1-10 and Lehman AF, ...

      Known for Psychosocial Treatment | Schizophrenia Port | Summary Statements | Token Economy | Cognitive Remediation
      KOL-Index: 11554

      BACKGROUND: Bipolar disorder is associated with deficits in cognitive functioning. The etiology of cognitive impairment in bipolar disorder may relate to both genetic and environmental factors. A valine/methionine polymorphism of the catechol O-methyltransferase gene at amino acid 158 (COMT Val158Met polymorphism) has been identified as a risk factor for cognitive impairment in schizophrenia. Serological evidence of infection with herpes simplex virus type 1 (HSV-1) has also been ...

      Known for Cognitive Impairment | Bipolar Disorder | Val158met Polymorphism | Serological Evidence | Herpes Simplex
      KOL-Index: 11536

      Latent infection with neurotropic herpes viruses, such as herpes simplex virus, type 1 (HSV1), has been generally considered benign in most immunocompetent individuals except for rare cases of encephalitis. However, several recent studies have shown impaired cognitive functions among individuals with schizophrenia exposed to HSV1 compared with schizophrenia patients not exposed to HSV1. Such impairments are robust and are prominently observed in working memory, verbal memory, and ...

      Known for Cognitive Impairment | Simplex Virus | Hsv1 Exposure | Type 1 | Schizophrenia Patients
      KOL-Index: 11426

      BACKGROUND: Increased immune sensitivity to gluten has been reported in schizophrenia. However, studies are inconsistent about this association.

      METHODS: The sample of 471 individuals included 129 with recent-onset psychosis, 191 with multi-episode schizophrenia, and 151 controls. Immunoglobulin (Ig)G and IgA antibodies to gliadin and to tissue transglutaminase, and IgG antibodies to deamidated gliadin were measured. Quantitative levels of antibodies in the psychiatric groups were ...

      Known for Celiac Disease | Gluten Sensitivity | Onset Psychosis | Episode Schizophrenia | Levels Antibodies
      KOL-Index: 11375

      Cognitive dysfunction is an important feature of schizophrenia and bipolar disorder. There is uncertainty about the relative magnitude of cognitive deficits in these disorders. We evaluated a total of 446 individuals: 229 with schizophrenia, 117 with bipolar disorder, and 100 controls without a history of psychiatric disorder. All participants were administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), a cognitive screening battery that evaluated ...

      Known for Bipolar Disorder | Repeatable Battery | Cognitive Functioning | Neuropsychological Status | Schizophrenia Severity
      KOL-Index: 11283

      Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological ...

      Known for Bipolar Disorder | Cognitive Functioning | Toxoplasma Gondii | Nonpsychiatric Controls | Neuropsychological Status

      Key People For Bipolar Disorder

      Top KOLs in the world
      #1
      Eduardo Eduard
      bipolar disorder cognitive impairment acute mania
      #2
      Robert M Post
      bipolar disorder affective illness depressed patients
      #3
      Susan L McElroy
      bipolar disorder binge eating bulimia nervosa
      #4
      Paul E Keck
      bipolar disorder acute mania united states
      #5
      Joseph R Calabrese
      bipolar disorder suicidal ideation rapid cycling
      #6
      Gary S Sachs
      bipolar disorder rapid cycling acute mania

      Sheppard Pratt, Baltimore, MD | Sheppard Pratt, Baltimore, MD, USA | College of Medicine, University of Arizona, Tucson, AZ, USA | Sheppard Pratt, Baltimore, MD 21204, USA;, faithbdickerson@gmail.com | Sheppard Pratt Health System, Baltimore, MD, USA

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.